Alembic Pharmaceuticals Limited

NSE:APLLTD.NS

1145.55 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010
Operating Activities:
Net Income 6,158.23,545.96,201.113,680.89,998.27,493.25,412.75,253.69,356.0193,590.7153,106.1112,063.5421,609.8241,068.433
Depreciation & Amortization 2,726.72,754.32,867.81,834.71,573.21,152.31,054.6829.7722.136444.129404.872349.686336.498295.917
Deferred Income Tax 00000000000000
Stock Based Compensation 00000000000000
Change In Working Capital -956.5-575.6-3,673.42,395.4-5,928.41,085.2-1,808.5-1,965.31,345.633-1,625.025-720.72438.593-626.229-488.843
Accounts Receivables 390.5-2,228.8-4,696.25,109.3-3,582.6361.9-1,841.8117.146-1,306.376-588.21-361.34100
Inventory -1,682.81,344.4-1,235.5-2,986.2-2,202.7-2,333.3-1,011.8-629.6-1,948.092-719.924-439.448-80.918-395.096-62.868
Accounts Payables 560.4-281.7366.7452.7-211.1-527.72,588.4-875.72,644.900000
Other Working Capital -224.6590.51,891.6-180.4683,584.3-796.7-1,335.73,293.725-905.101-281.272519.511-231.133-425.975
Other Non Cash Items 5,8151,514.9128-3,277.1-1,151.7-1,611.1-1,534.6-1,230-2,119.86-692.222-428.055-203.65887.31386.303
Operating Cash Flow 7,558.17,239.55,523.514,633.84,491.38,119.63,124.22,8889,303.9281,717.5972,362.2082,648.1631,407.406961.81
Investing Activities:
Investments In Property Plant And Equipment -3,274.7-4,434.1-4,256.4-6,595.1-7,349-7,643.7-8,217.5-4,703.8-3,036.158-2,235.826-819.627-859.733-612.563-625.377
Acquisitions Net 115.618.746.1-4.66-143.6-784.1194.11.300000
Purchases Of Investments -83.2-70-1,392.9-1,861-15.2-143.600-81.274-341.8920000
Sales Maturities Of Investments 0-18.71,869.71,8619.2143.6036000000
Other Investing Activites 16.428.213.8-1,788.432.7231.3157.820612.67721.5919.007189.51848.66757.301
Investing Cash Flow -3,226-4,475.9-3,719.7-8,388.1-7,316.3-7,556-8,843.8-4,461.8-3,104.755-2,556.127-810.62-670.215-563.896-568.076
Financing Activities:
Debt Repayment -2,054.1-2,000-3,000-3,792.7-2,000-6,043.9-6,190.5-381.2-1,264.119-371.991-854.298-1,700.906-514.3980
Common Stock Issued 0007,340.8000000000110
Common Stock Repurchased 00000000000000
Dividends Paid -1,572.5-1,965.6-2,751.90-3,259.7-909.1-907.6-901-652.7-654.964-545.779-303.623-216.4490
Other Financing Activities -0.21,3463,578.4-9,522.46,808.27,543.45,933.9-6.5-42.321,894.127-110.487-283.256295.249-591.474
Financing Cash Flow -3,884.8-2,619.6-2,173.5-5,974.31,548.5590.45,026.3-1,288.7-1,959.139867.172-1,510.564-2,287.785-435.598-481.474
Other Information:
Effect Of Forex Changes On Cash 0-0.010-9.34.1-0.7-0.10.100.002-0.001000
Net Change In Cash 443143.9-369.7262.2-1,272.31,153.3-693.4-2,862.44,240.03428.64441.023-309.837407.912-87.74
Cash At End Of Period 1,265.7754.8610.9980.6718.41,990.7837.41,530.84,508.29268.256202.083161.06470.80562.893